2016
DOI: 10.21767/2471-8084.100011
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Oleuropein Aglycone in the Treatment of Transthyretin-Amyloidosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 35 publications
(39 reference statements)
0
1
0
Order By: Relevance
“…In addition, it may also hinder the binding of α‐synuclein aggregates to cell membrane components thus preventing cell oxidative damage (Palazzi et al., 2018). Leri and Bucciantini (2016) reported that oleuropein aglycone could inhibit the toxic effects of transthyretin (TTR) amyloid and be important to prevent or treat heart and liver complications. It has also been shown to be capable of preventing or delaying the progression of type 2 diabetes (Rigacci et al., 2010) and obesity (Oi‐Kano et al., 2017).…”
Section: Applications Of the Main Bioactive Compounds Extracted From ...mentioning
confidence: 99%
“…In addition, it may also hinder the binding of α‐synuclein aggregates to cell membrane components thus preventing cell oxidative damage (Palazzi et al., 2018). Leri and Bucciantini (2016) reported that oleuropein aglycone could inhibit the toxic effects of transthyretin (TTR) amyloid and be important to prevent or treat heart and liver complications. It has also been shown to be capable of preventing or delaying the progression of type 2 diabetes (Rigacci et al., 2010) and obesity (Oi‐Kano et al., 2017).…”
Section: Applications Of the Main Bioactive Compounds Extracted From ...mentioning
confidence: 99%